Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | ap endonuclease, putative | 0.002 | 0.2203 | 1 |
Echinococcus granulosus | GPCR family 2 | 0.0017 | 0.1639 | 0.1639 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD2 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0025 | 0.3115 | 0.3115 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.002 | 0.2203 | 0.5 |
Brugia malayi | AMP-binding enzyme family protein | 0.0025 | 0.3115 | 0.3905 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0054 | 0.7978 | 1 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.002 | 0.2203 | 0.5 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD3 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0018 | 0.182 | 0.182 |
Trypanosoma brucei | apurinic/apyrimidinic endonuclease, putative | 0.002 | 0.2203 | 1 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0065 | 1 | 1 |
Onchocerca volvulus | 0.0025 | 0.3115 | 1 | |
Trichomonas vaginalis | ap endonuclease, putative | 0.002 | 0.2203 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0037 | 0.5044 | 0.6322 |
Mycobacterium ulcerans | fatty-acid-CoA ligase | 0.0025 | 0.3115 | 0.3115 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0017 | 0.1639 | 0.1639 |
Loa Loa (eye worm) | hypothetical protein | 0.0054 | 0.7978 | 1 |
Mycobacterium leprae | PROBABLE FATTY-ACID-CoA LIGASE FADD7 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) | 0.0025 | 0.3115 | 1 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.002 | 0.2203 | 0.2762 |
Brugia malayi | AMP-binding enzyme family protein | 0.0025 | 0.3115 | 0.3905 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0017 | 0.1639 | 0.2055 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0017 | 0.1639 | 0.1639 |
Entamoeba histolytica | acyl-CoA synthetase, putative | 0.0025 | 0.3115 | 1 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0025 | 0.3115 | 0.3115 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.002 | 0.2203 | 0.5 |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.002 | 0.2203 | 0.2203 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0025 | 0.3115 | 0.3115 |
Mycobacterium ulcerans | fatty-acid-CoA ligase | 0.0019 | 0.2 | 0.2 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.2 | 0.2507 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0054 | 0.7978 | 1 |
Mycobacterium tuberculosis | Probable chain -fatty-acid-CoA ligase FadD13 (fatty-acyl-CoA synthetase) | 0.0025 | 0.3115 | 0.3115 |
Loa Loa (eye worm) | hypothetical protein | 0.0025 | 0.3115 | 0.3905 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD7 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0018 | 0.182 | 0.182 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD5 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0018 | 0.182 | 0.182 |
Schistosoma mansoni | hypothetical protein | 0.0017 | 0.1639 | 0.1639 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.0065 | 1 | 1 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0017 | 0.1639 | 0.2055 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0025 | 0.3115 | 0.3115 |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.002 | 0.2203 | 0.2203 |
Plasmodium falciparum | acyl-CoA synthetase | 0.0019 | 0.2 | 0.9078 |
Brugia malayi | AMP-binding enzyme family protein | 0.0025 | 0.3115 | 0.3905 |
Schistosoma mansoni | hypothetical protein | 0.0017 | 0.1639 | 0.1639 |
Mycobacterium ulcerans | long-chain-fatty-acid--CoA ligase | 0.0025 | 0.3115 | 0.3115 |
Loa Loa (eye worm) | hypothetical protein | 0.0037 | 0.5044 | 0.6322 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0065 | 1 | 1 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0025 | 0.3115 | 0.3115 |
Mycobacterium ulcerans | long-chain fatty-acid CoA ligase | 0.0025 | 0.3115 | 0.3115 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.002 | 0.2203 | 0.2203 |
Mycobacterium leprae | PROBABLE FATTY-ACID-CoA LIGASE FADD2 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) | 0.0025 | 0.3115 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0017 | 0.1639 | 0.1639 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0025 | 0.3115 | 0.3115 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.002 | 0.2203 | 0.2762 |
Mycobacterium ulcerans | long-chain-fatty-acid-CoA ligase | 0.0025 | 0.3115 | 0.3115 |
Toxoplasma gondii | exonuclease III APE | 0.002 | 0.2203 | 0.2203 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.002 | 0.2203 | 1 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0025 | 0.3115 | 0.3115 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0065 | 1 | 1 |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.002 | 0.2203 | 1 |
Echinococcus multilocularis | GPCR, family 2 | 0.0017 | 0.1639 | 0.1639 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0054 | 0.7978 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.2 | 0.2507 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0065 | 1 | 1 |
Entamoeba histolytica | acyl-CoA synthetase, putative | 0.0025 | 0.3115 | 1 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0065 | 1 | 1 |
Entamoeba histolytica | acyl-coA synthetase, putative | 0.0025 | 0.3115 | 1 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.002 | 0.2203 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0037 | 0.5044 | 0.5044 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.002 | 0.2203 | 0.7073 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.002 | 0.2203 | 1 |
Schistosoma mansoni | ap endonuclease | 0.002 | 0.2203 | 0.2203 |
Plasmodium vivax | acyl-CoA synthetase, putative | 0.0019 | 0.2 | 0.9078 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD35 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0018 | 0.182 | 0.182 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0017 | 0.1639 | 0.2055 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.2 | 0.2507 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0065 | 1 | 1 |
Schistosoma mansoni | ap endonuclease | 0.002 | 0.2203 | 0.2203 |
Mycobacterium ulcerans | hypothetical protein | 0.0025 | 0.3115 | 0.3115 |
Leishmania major | apurinic/apyrimidinic endonuclease-redox protein | 0.002 | 0.2203 | 0.2203 |
Schistosoma mansoni | hypothetical protein | 0.0017 | 0.1639 | 0.1639 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0017 | 0.1639 | 0.1639 |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.1639 | 0.2055 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0065 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0025 | 0.3115 | 0.3905 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.2 | 0.2507 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.2 | 0.2507 |
Loa Loa (eye worm) | hypothetical protein | 0.0025 | 0.3115 | 0.3905 |
Chlamydia trachomatis | acylglycerophosphoethanolamine acyltransferase | 0.0019 | 0.2 | 0.5 |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.002 | 0.2203 | 0.2203 |
Mycobacterium tuberculosis | Fatty-acid-AMP ligase FadD30 (fatty-acid-AMP synthetase) (fatty-acid-AMP synthase) | 0.0019 | 0.2 | 0.2 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0017 | 0.1639 | 0.1639 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0065 | 1 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.